HCP (HCP) Given a $21.00 Price Target at UBS Group

UBS Group set a $21.00 price objective on HCP (NYSE:HCP) in a research report released on Wednesday morning. The firm currently has a sell rating on the real estate investment trust’s stock.

Several other analysts have also weighed in on the company. Zacks Investment Research lowered HCP from a hold rating to a sell rating in a report on Tuesday, January 2nd. Stifel Nicolaus upgraded HCP from a hold rating to a buy rating and set a $29.00 price objective for the company in a report on Tuesday, December 5th. JPMorgan Chase & Co. upgraded HCP from a neutral rating to an overweight rating and set a $29.00 price objective for the company in a report on Friday, December 15th. Mizuho raised HCP from a neutral rating to a buy rating and set a $32.00 target price on the stock in a research report on Thursday, November 2nd. Finally, Morgan Stanley reaffirmed an equal weight rating and set a $29.00 target price on shares of HCP in a research report on Thursday, December 14th. Four analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have given a buy rating to the company’s stock. The company currently has a consensus rating of Hold and a consensus target price of $28.31.

Shares of HCP (NYSE HCP) opened at $21.80 on Wednesday. The company has a quick ratio of 0.31, a current ratio of 0.31 and a debt-to-equity ratio of 1.23. The firm has a market capitalization of $10,230.00, a price-to-earnings ratio of 23.70, a PEG ratio of 4.15 and a beta of 0.22. HCP has a twelve month low of $21.64 and a twelve month high of $33.67.

HCP (NYSE:HCP) last announced its quarterly earnings data on Tuesday, February 13th. The real estate investment trust reported $0.48 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.47 by $0.01. The business had revenue of $443.30 million during the quarter, compared to analyst estimates of $448.54 million. HCP had a return on equity of 6.99% and a net margin of 22.37%. The company’s revenue was down 17.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.59 earnings per share. analysts forecast that HCP will post 1.82 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, March 2nd. Stockholders of record on Thursday, February 15th will be given a dividend of $0.37 per share. This represents a $1.48 dividend on an annualized basis and a dividend yield of 6.79%. The ex-dividend date is Wednesday, February 14th. HCP’s dividend payout ratio (DPR) is presently 160.87%.

In related news, insider Kendall K. Young bought 14,000 shares of the business’s stock in a transaction dated Wednesday, February 14th. The shares were bought at an average cost of $21.91 per share, with a total value of $306,740.00. Following the completion of the transaction, the insider now directly owns 48,544 shares of the company’s stock, valued at $1,063,599.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.22% of the stock is owned by insiders.

Several institutional investors have recently made changes to their positions in the company. Advisory Services Network LLC raised its position in HCP by 4.1% during the second quarter. Advisory Services Network LLC now owns 3,782 shares of the real estate investment trust’s stock valued at $121,000 after buying an additional 150 shares during the period. Vestpro Financial Partners Inc. dba CPF Texas acquired a new position in HCP during the fourth quarter valued at $103,000. Fieldpoint Private Securities LLC acquired a new position in HCP during the third quarter valued at $147,000. Penserra Capital Management LLC acquired a new position in HCP during the third quarter valued at $163,000. Finally, First City Capital Management Inc. acquired a new position in HCP during the third quarter valued at $212,000. 90.78% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION NOTICE: This story was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this story on another publication, it was illegally copied and reposted in violation of U.S. & international trademark and copyright laws. The original version of this story can be viewed at https://www.dispatchtribunal.com/2018/02/22/hcp-hcp-given-a-21-00-price-target-at-ubs-group.html.

About HCP

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Analyst Recommendations for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply